XML 60 R100.htm IDEA: XBRL DOCUMENT v3.19.3
Disposition - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Nov. 20, 2019
Dec. 14, 2016
Apr. 01, 2017
Sep. 28, 2019
Sep. 29, 2018
Sep. 30, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Proceeds from divestiture of businesses       $ 0.0 $ 0.0 $ 1,865.0
Blood Screening Business | Disposed of by Sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Sales price   $ 1,850.0        
Proceeds from divestiture of businesses     $ 1,865.0      
Gain on disposal     899.7      
Tax obligation     649.5      
Proceeds allocated to manufacture of inventory     $ 13.1      
Disposal group, revenue       $ 58.5 $ 55.4 $ 44.0
Minimum            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Transition services agreement term     2 years      
Minimum | Blood Screening Business | Disposed of by Sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Transition services agreement term   2 years        
Maximum            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Transition services agreement term     3 years      
Maximum | Blood Screening Business | Disposed of by Sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Transition services agreement term   3 years        
Subsequent Event | Medical Aesthetics Business            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Sales price $ 138.0          
Proceeds from divestiture of businesses $ 205.0